GLP-1 Weight Loss Medications May Reduce Cancer Risk, New Study Reveals
As the landscape of metabolic medicine continues to evolve, researchers are increasingly examining whether medications originally designed for weight management and glycemic control—specifically GLP-1 receptor agonists—might offer protective benefits beyond their primary indications. A growing body of scientific inquiry is now exploring the potential for these therapies to influence the progression of certain malignancies, sparking … Read more